M L Sumelahti1, P J Tienari, J Wikström, J Palo, M Hakama. 1. School of Public Health, University of Tampere and Department of Clinical Neurophysiology, Tampere University Hospital, Finland. memasu@uta.fi
Abstract
OBJECTIVES: To follow-up the prevalence trends of MS from 1983 to 1993 in western and southern Finland. MS epidemiology has been previously followed from 1964 to 1978 in these regions. The updated prevalences were correlated with incidence trends in the same period. METHODS: Age-adjusted and age-specific MS prevalence rates were calculated for cases classified by Poser's criteria. RESULTS: In the western health-care districts, Seinäjoki and Vaasa, prevalences in 1993 were 202/10(5) and 111/10(5). In the southern district Uusimaa the respective figure was 108/10(5). In Seinäjoki a significant 1.7-fold increase was found in 1993 as compared to 1983, mainly due to increased incidence. In Uusimaa a significant 1.2-fold increase in prevalence was found in the presence of stable incidence. In Vaasa prevalence was stable, although incidence was declining. CONCLUSION: The prevalence of MS is increasing in Seinäjoki and Uusimaa but not in Vaasa. Both the prevalence and incidence in Seinäjoki are now among the highest reported.
OBJECTIVES: To follow-up the prevalence trends of MS from 1983 to 1993 in western and southern Finland. MS epidemiology has been previously followed from 1964 to 1978 in these regions. The updated prevalences were correlated with incidence trends in the same period. METHODS: Age-adjusted and age-specific MS prevalence rates were calculated for cases classified by Poser's criteria. RESULTS: In the western health-care districts, Seinäjoki and Vaasa, prevalences in 1993 were 202/10(5) and 111/10(5). In the southern district Uusimaa the respective figure was 108/10(5). In Seinäjoki a significant 1.7-fold increase was found in 1993 as compared to 1983, mainly due to increased incidence. In Uusimaa a significant 1.2-fold increase in prevalence was found in the presence of stable incidence. In Vaasa prevalence was stable, although incidence was declining. CONCLUSION: The prevalence of MS is increasing in Seinäjoki and Uusimaa but not in Vaasa. Both the prevalence and incidence in Seinäjoki are now among the highest reported.
Authors: Eveliina Jakkula; Karola Rehnström; Teppo Varilo; Olli P H Pietiläinen; Tiina Paunio; Nancy L Pedersen; Ulf deFaire; Marjo-Riitta Järvelin; Juha Saharinen; Nelson Freimer; Samuli Ripatti; Shaun Purcell; Andrew Collins; Mark J Daly; Aarno Palotie; Leena Peltonen Journal: Am J Hum Genet Date: 2008-12 Impact factor: 11.025
Authors: Eveliina Jakkula; Virpi Leppä; Anna-Maija Sulonen; Teppo Varilo; Suvi Kallio; Anu Kemppinen; Shaun Purcell; Keijo Koivisto; Pentti Tienari; Marja-Liisa Sumelahti; Irina Elovaara; Tuula Pirttilä; Mauri Reunanen; Arpo Aromaa; Annette Bang Oturai; Helle Bach Søndergaard; Hanne F Harbo; Inger-Lise Mero; Stacey B Gabriel; Daniel B Mirel; Stephen L Hauser; Ludwig Kappos; Chris Polman; Philip L De Jager; David A Hafler; Mark J Daly; Aarno Palotie; Janna Saarela; Leena Peltonen Journal: Am J Hum Genet Date: 2010-02-12 Impact factor: 11.025
Authors: Suvi P Kallio; Eveliina Jakkula; Shaun Purcell; Minna Suvela; Keijo Koivisto; Pentti J Tienari; Irina Elovaara; Tuula Pirttilä; Mauri Reunanen; Denis Bronnikov; Markku Viander; Seppo Meri; Jan Hillert; Frida Lundmark; Hanne F Harbo; Aslaug R Lorentzen; Philip L De Jager; Mark J Daly; David A Hafler; Aarno Palotie; Leena Peltonen; Janna Saarela Journal: Hum Mol Genet Date: 2009-02-16 Impact factor: 6.150
Authors: Anna-Maija Sulonen; Suvi P Kallio; Pekka Ellonen; Minna Suvela; Irina Elovaara; Keijo Koivisto; Tuula Pirttilä; Mauri Reunanen; Pentti J Tienari; Aarno Palotie; Leena Peltonen; Janna Saarela Journal: J Neuroimmunol Date: 2008-11-18 Impact factor: 3.478
Authors: Janna Saarela; Suvi P Kallio; Daniel Chen; Alexandre Montpetit; Anne Jokiaho; Eva Choi; Rosanna Asselta; Denis Bronnikov; Matthew R Lincoln; A Dessa Sadovnick; Pentti J Tienari; Keijo Koivisto; Aarno Palotie; George C Ebers; Thomas J Hudson; Leena Peltonen Journal: PLoS Genet Date: 2006-03-31 Impact factor: 5.917
Authors: Silja Särkijärvi; Hanna Kuusisto; Raija Paalavuo; Mari Levula; Nina Airla; Terho Lehtimäki; Jaakko Kaprio; Markku Koskenvuo; Irina Elovaara Journal: BMC Med Genet Date: 2006-02-27 Impact factor: 2.103